Asamedic AS is a Norwegian pharmaceutical company established in 2013, dedicated to developing innovative over-the-counter (OTC) products. The company has made significant strides in the pharmaceutical industry with the successful launch of Coxor in Norway in 2023. This liquid variant of ASA has received strong endorsement from key opinion leaders, authorities, and the public, highlighting its impact in the market. Asamedic is actively working on regulatory approvals in other regions and is seeking licensing partners for both European countries and additional geographic areas.

Services include:
– Anatomical Therapeutic Chemical (ATC) Classification
– Finished Dosage Forms

Asamedic AS continues to position itself as a significant player in the pharmaceutical sector, focusing on quality and innovation in its offerings. For more information, visit asamedic.no.